摘要
目的 探讨晚期乳腺癌有效的治疗手段。方法 对 31例晚期乳腺癌采用冷冻免疫配合以表阿霉素为主联合化疗 (治疗组 )和 31例晚期乳腺癌采用生物免疫制剂配合传统的 CAF方案化疗 (对照组 )在疗效、毒副反应、免疫水平进行比较分析。结果 治疗组化疗有效率 6 7.7% ,显著优于对照组化疗有效率 5 1.6 % (P<0 .0 5 ) ;冷冻免疫治疗的患者在化疗一周后免疫水平继续提高 ,和单纯生物免疫制剂化疗一周后明显下降相比较有显著差异 (P<0 .0 5 ) ,治疗组化疗骨髓抑制低于对照组。
Objective To investigate the operative therapeutic means of advanced mammary cancer Method To Comparison of the effect,poison ill response and Immune marker between with the program of CAF and self bodies Freezing Immunity alliance the synapse chemiotherapy with the main of epirubicin in 31 cases advanced mammary cancer Result The efficial rate of the group of freezing immunity alliance the synapse chemiotherapy with the main of epirubicin was 58 1%,and the efficial rate of the group of CAF was 41 9%,apparently,the first was better than the latter (P<0 05) To use freezing immunity treatment,the patients's immunological function was rised continuely after chemiotherapy,while to use the biological Immune Agent,the patients's immunological function was decreased after chemiotherapy (the first is the latter:P<0 05) the Bone marrow depression in the group of freezing immunity alliance the synapse chemiotherapy with the main of epirubicin was lower than that of CAF Conclusion The colligation treatment method of Freezing Immunity alliance the synapse chemiotherapy with the main of epirubicin was one of the operative therapeutic method to treat the advanced mammary cancer
出处
《医学文选》
2001年第3期271-273,共3页
Anthology of Medicine
关键词
冷冻免疫
联合化疗
晚期乳腺癌
治疗
Freezing Immunity
the synapse chemiotherapy with the main of epirubicin:advanced mammary cancer
